Canadian multicenter susceptibility study, with a focus on cephalosporins, from 15 Canadian medical centers

被引:13
作者
Blondeau, JM
Yaschuk, Y
Smith, JA
Noble, MA
Kibsey, P
Horsman, GB
Hoban, DJ
Colby, WD
Jessamine, P
Simor, AE
Low, DE
Bourgault, AM
Laverdiere, M
Kuhn, M
MacDonald, S
Brown, H
机构
[1] DIV CLIN MICROBIOL,SASKATOON,SK,CANADA
[2] DIST HLTH,SASKATOON,SK,CANADA
[3] ST PAULS HOSP GREY NUNS,SASKATOON,SK,CANADA
[4] UNIV SASKATCHEWAN,SASKATOON,SK S7N 0W0,CANADA
[5] VANCOUVER GEN HOSP,VANCOUVER,BC,CANADA
[6] UNIV HOSP,VANCOUVER,BC,CANADA
[7] GREY NUNS HOSP,EDMONTON,AB,CANADA
[8] HE ROBERTSON LAB,REGINA,SK,CANADA
[9] HLTH SCI CTR,WINNIPEG,MB,CANADA
[10] UNIV HOSP,LONDON,ON,CANADA
[11] OTTAWA CIVIC HOSP,OTTAWA,ON K1Y 4E9,CANADA
[12] SUNNYBROOK MED CTR,TORONTO,ON M4N 3M5,CANADA
[13] MT SINAI HOSP,TORONTO,ON M5G 1X5,CANADA
[14] HOP ST LUC,MONTREAL,PQ H2X 1P1,CANADA
[15] HOP MAISON NEUVE ROSEMONT,MONTREAL,PQ H1T 2M4,CANADA
[16] MONCTON HOSP,MONCTON,NB,CANADA
[17] HALIFAX INFIRM,HALIFAX,NS,CANADA
[18] HLTH SCI CTR,ST JOHNS,NF,CANADA
关键词
D O I
10.1128/AAC.41.12.2773
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
We have previously reported on the in vitro susceptibilities of 4,482 microorganisms to 10 antimicrobial agents tested as part of a Canadian multicenter study. We now report on the remaining 10 agents tested in that study. Of the cephalosporins reported here, ceftriaxone had the greatest activity (82 to 100% susceptible isolates) against Enterobacteriaceae, compared to ceftizoxime (78 to 100%) and cefoperazone (78 to 100%). Cefoperazone activity against Pseudomonas aeruginosa was 87%, compared to 92% for ticarcillin-clavulanate. All agents had 97% or greater activity against Staphylococcus aureus.
引用
收藏
页码:2773 / 2775
页数:3
相关论文
共 6 条
[1]   Canadian ciprofloxacin susceptibility study: Comparative study from 15 medical centers [J].
Blondeau, JM ;
Yaschuk, Y .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (07) :1729-1732
[2]   ANTIBIOTIC SUSCEPTIBILITY PROFILES OF 941 GRAM-NEGATIVE BACTERIA ISOLATED FROM SEPTICEMIC PATIENTS THROUGHOUT CANADA [J].
CHAMBERLAND, S ;
LECUYER, J ;
LESSARD, C ;
BERNIER, M ;
PROVENCHER, P ;
BERGERON, MG .
CLINICAL INFECTIOUS DISEASES, 1992, 15 (04) :615-628
[3]  
FEKETE T, 1996, AM J MED S6A, V100
[4]  
*NAT COMM CLIN LAB, 1993, APPR STAND M7 A2 MET
[5]  
THORNSBERRY C, 1996, AM J MED S6A, V100
[6]   CANADIAN SURVEY OF ANTIMICROBIAL RESISTANCE IN KLEBSIELLA SPP AND ENTEROBACTER SPP [J].
TOYE, BW ;
SCRIVER, SR ;
LOW, DE ;
FORWARD, KR ;
MACKENZIE, AMR ;
PHILLIPS, AM ;
WALMSLEY, SL ;
SIMOR, AE ;
GREGSON, DB ;
ALFA, MJ ;
HOBAN, DJ ;
KIBSEY, PC ;
SMITH, JA .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1993, 32 :81-86